Search research articles
Contact Us
Filters
Showing results (531-540 of 589) with videos related to
Page
of 59
Sort By:
Neurology
|
September 13, 2015
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
R Scott Turner, Ronald G Thomas, Suzanne Craft, et al.
Neuroimage. Clinical
|
October 6, 2018
Microstructural brain changes track cognitive decline in mild cognitive impairment
Emilie T Reas, Donald J Hagler, Nathan S White, et al.
Plant Direct
|
May 14, 2020
Hydroxyl carlactone derivatives are predominant strigolactones in <i>Arabidopsis</i>
Kaori Yoneyama, Kohki Akiyama, Philip B Brewer, et al.
Journal of Alzheimer'S Disease : JAD
|
December 5, 2019
Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia
Emilie T Reas, Donald J Hagler, Joshua M Kuperman, et al.
Neurology
|
September 4, 2020
Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults
Alexandra J Weigand, Mark W Bondi, Kelsey R Thomas, et al.
Neurobiology of Aging
|
August 16, 2021
Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap?
Sarah J Banks, Murray J Andrews, Leonardino Digma, et al.
Journal of Environmental Quality
|
September 26, 2025
Recycling waste via insect agriculture: Frass impacts on soil and plant health
Helen C S Amorim, Amanda J Ashworth, Thomas F Ducey, et al.
AJNR. American Journal of Neuroradiology
|
September 15, 2012
Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease
R S Desikan, L K McEvoy, D Holland, et al.
Circulation
|
December 1, 1984
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin
J M Hoeg, M B Maher, E Bou, et al.
JAMA Neurology
|
January 1, 2014
The role of clusterin in amyloid-β-associated neurodegeneration
Rahul S Desikan, Wesley K Thompson, Dominic Holland, et al.
Page
of 59
Search research articles
Search
Showing results (531-540 of 589) with videos related to
Sort By:
Page
of 59
Neurology
|
September 13, 2015
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
R Scott Turner, Ronald G Thomas, Suzanne Craft, et al.
Neuroimage. Clinical
|
October 6, 2018
Microstructural brain changes track cognitive decline in mild cognitive impairment
Emilie T Reas, Donald J Hagler, Nathan S White, et al.
Plant Direct
|
May 14, 2020
Hydroxyl carlactone derivatives are predominant strigolactones in <i>Arabidopsis</i>
Kaori Yoneyama, Kohki Akiyama, Philip B Brewer, et al.
Journal of Alzheimer'S Disease : JAD
|
December 5, 2019
Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia
Emilie T Reas, Donald J Hagler, Joshua M Kuperman, et al.
Neurology
|
September 4, 2020
Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults
Alexandra J Weigand, Mark W Bondi, Kelsey R Thomas, et al.
Neurobiology of Aging
|
August 16, 2021
Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap?
Sarah J Banks, Murray J Andrews, Leonardino Digma, et al.
Journal of Environmental Quality
|
September 26, 2025
Recycling waste via insect agriculture: Frass impacts on soil and plant health
Helen C S Amorim, Amanda J Ashworth, Thomas F Ducey, et al.
AJNR. American Journal of Neuroradiology
|
September 15, 2012
Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease
R S Desikan, L K McEvoy, D Holland, et al.
Circulation
|
December 1, 1984
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin
J M Hoeg, M B Maher, E Bou, et al.
JAMA Neurology
|
January 1, 2014
The role of clusterin in amyloid-β-associated neurodegeneration
Rahul S Desikan, Wesley K Thompson, Dominic Holland, et al.
Page
of 59